Mary T. Mulagha

Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy

Stephen T. Sonis, June Eilers, Joel B. Epstein et al. · Cancer · 1999 · 401 citations

Dentistry, Oncology, Radiation Oncology +14

Fadrozole HCL (CGS-16949A) versus megestrol acetate treatment of postmenopausal patients with metastatic breast carcinoma: Results of two randomized double blind controlled multiinstitutional trials

Aman U. Buzdar, Robert Smith, Charles L. Vogel et al. · Cancer · 1996 · 119 citations

Medicine, Oncology, Pharmacology +17

A phase I trial of CGS 16949a. A new aromatase inhibitor

Allan Lipton, Harold A. Harvey, Laurence M. Demers et al. · Cancer · 1990 · 67 citations · Full text

Medicine, Oncology, Pharmacology +17

Specificity of Low Dose Fadrozole Hydrochloride (CGS 16949A) as an Aromatase Inhibitor

Richard J. Santen, L. M. Demers, James Lynch et al. · The Journal of Clinical Endocrinology & Metabolism · 1991 · 47 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

The Pharmacodynamic Inhibition of Estrogen Synthesis by Fadrozole, an Aromatase Inhibitor, and Its Pharmacokinetic Disposition

Gregory M. Kochak, Surinder Mangat, Mary T. Mulagha et al. · The Journal of Clinical Endocrinology & Metabolism · 1990 · 23 citations

Medicine, Endocrinology, Pharmacology +17